{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:06:37Z","timestamp":1791983197040,"version":"4.4.0"},"reference-count":28,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background\/Objectives: The present study aimed to analyze systemic antibiotic prescription patterns in the Salerno Local Health Authority (ASL Salerno) during 2024. The objective was to describe territorial antibiotic consumption and monitor prescribing appropriateness from epidemiological, pharmacological, and antimicrobial stewardship perspectives, using the World Health Organization (WHO) AWaRe classification system as a reference. Methods: A retrospective analysis of antibiotic prescriptions was conducted across ASL Salerno in 2024. Total prescription and associated expenditures were assessed, along with distribution across districts and pharmacological classes. Antibiotics were categorized according to the Anatomical Therapeutic Chemical (ATC) system and further classified using the WHO AWaRe framework (Access, Watch, Reserve) to evaluate prescribing appropriateness and potential patterns of antimicrobial resistance. Results: More than 1 million antibiotic prescriptions were recorded, totaling approximately \u20ac15 million in expenditure. Prescribing patterns showed a predominance of penicillins and cephalosporins, followed by macrolides, fluoroquinolones, and J01X class. A substantial proportion of prescriptions belonged to the Watch category, particularly third-generation cephalosporins, fluoroquinolones, and fosfomycin. Some districts demonstrated a higher reliance on Watch antibiotics, while others showed increased use of Access agents such as amoxicillin, doxycycline, and amikacin. Conclusions: The surveillance analysis highlights significant variability in antibiotic prescribing practices within ASL Salerno and a substantial use of Watch-group antibiotics. These findings suggest the need for strengthened antimicrobial stewardship interventions, such as targeted education, auditing, and decision-support tools. Continuous monitoring of prescribing trends is essential to encourage appropriate antibiotic use and contribute to the containment of antimicrobial resistance.<\/jats:p>","DOI":"10.3390\/antibiotics15060612","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:56:31Z","timestamp":1781675791000},"page":"612","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["From Access to Watch: An AWaRe-Oriented Evaluation of Antibiotic Prescribing in ASL Salerno"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9690-907X","authenticated-orcid":false,"given":"Angelo","family":"Santoro","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of Salerno, 84084 Salerno, Italy"},{"name":"Scuola di Specializzazione in Farmacia Ospedaliera, Department of Pharmacy, University of Salerno, 84084 Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Toro","sequence":"additional","affiliation":[{"name":"Dipartimento Farmaceutico, Local Health Authority (ASL) of Salerno, 84124 Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Esposito","sequence":"additional","affiliation":[{"name":"Dipartimento Farmaceutico, Local Health Authority (ASL) of Salerno, 84124 Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lalli","sequence":"additional","affiliation":[{"name":"Fatebenefratelli Hospital, SIFO (\u201cSociet\u00e0 Italiana di Farmacia Ospedaliera e Dei Servizi Farmaceutici Delle Aziende Sanitarie\u201d) Campania Section, 80100 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniello","family":"Corallo","sequence":"additional","affiliation":[{"name":"Local Health Authority (ASL) of Salerno, SIFO (\u201cSociet\u00e0 Italiana di Farmacia Ospedaliera e dei Servizi Farmaceutici delle Aziende Sanitarie\u201d) Campania Section, 84131 Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4851-4276","authenticated-orcid":false,"given":"Francesca Futura","family":"Bernardi","sequence":"additional","affiliation":[{"name":"General Directorate for Health Protection, SIFO (\u201cSociet\u00e0 Italiana di Farmacia Ospedaliera e Dei Servizi Farmaceutici Delle Aziende Sanitarie\u201d) Campania Section, 80100 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Sosto","sequence":"additional","affiliation":[{"name":"General Directorate, Local Health Authority (ASL) of Salerno, 84134 Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Cillo","sequence":"additional","affiliation":[{"name":"Dipartimento Farmaceutico, Local Health Authority (ASL) of Salerno, 84124 Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"D\u2019Ursi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Salerno, 84084 Salerno, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1080\/10408398.2015.1077192","article-title":"Antimicrobial resistance: A global emerging threat to public health systems","volume":"57","author":"Ferri","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4274\/tjps.galenos.2020.11456","article-title":"Evaluation of prescribing patterns of antibiotics using selected indicators for antimicrobial use in hospitals and the access, watch, reserve (AWaRe) classification by the World Health Organization","volume":"18","author":"Mugada","year":"2021","journal-title":"Turk. J. Pharm. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"dlae110","DOI":"10.1093\/jacamr\/dlae110","article-title":"Patterns of community antibiotic use with reference to the AWaRe classification of the World Health Organization","volume":"6","author":"Gagliotti","year":"2024","journal-title":"JAC-Antimicrob. Resist."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Rashid, M.M., Akhtar, Z., Chowdhury, S., Islam, M.A., Parveen, S., Ghosh, P.K., Rahman, A., Khan, Z.H., Islam, K., and Debnath, N. (2022). Pattern of antibiotic use among hospitalized patients according to WHO access, Watch, reserve (AWaRe) classification: Findings from a point prevalence survey in Bangladesh. Antibiotics, 11.","DOI":"10.3390\/antibiotics11060810"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13756-019-0620-5","article-title":"Prescribing practices using WHO prescribing indicators and factors associated with antibiotic prescribing in six community pharmacies in Asmara, Eritrea: A cross-sectional study","volume":"8","author":"Amaha","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"dlaf031","DOI":"10.1093\/jacamr\/dlaf031","article-title":"Increasing the use of the WHO AWaRe system in antibiotic surveillance and stewardship programmes in low-and middle-income countries","volume":"7","author":"Saleem","year":"2025","journal-title":"JAC-Antimicrob. Resist."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hollingworth, S., and Kairuz, T. (2021). Measuring medicine use: Applying ATC\/DDD methodology to real-world data. Pharmacy, 9.","DOI":"10.3390\/pharmacy9010060"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.ajic.2024.07.007","article-title":"Antibiotic prescription prevalence in Iranian outpatients: A focus on defined daily doses and the AWaRe classification system","volume":"52","author":"Nasehi","year":"2024","journal-title":"Am. J. Infect. Control"},{"key":"ref_9","unstructured":"(ECDC) European Centre for Disease Prevention and Control (2025, December 15). Antimicrobial Consumption (AMC) Reporting Protocol 2023. The European Surveillance of Antimicrobial Consumption Network (ESAC-Net), Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/esac-net-reporting-protocol-2023."},{"key":"ref_10","unstructured":"World Health Organization (2021). WHO Access, Watch, Reserve (AWaRe) classification of antibiotics for evaluation and monitoring of use, 2021. WHO Access, Watch, Reserve (AWaRe) Classification of Antibiotics for Evaluation and Monitoring of Use, 2021, World Health Organization."},{"key":"ref_11","unstructured":"Shutter, M.C., and Akhondi, H. (2019). Tetracycline. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_13","first-page":"43","article-title":"Antibiotics and drug pharmacology","volume":"3","author":"Adefegha","year":"2019","journal-title":"Acta Sci. Pharm. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Zhydzetski, A., G\u0142owacka-Grzyb, Z., Bukowski, M., \u017b\u0105d\u0142o, T., Bonar, E., and W\u0142adyka, B. (2024). Agents targeting the bacterial cell wall as tools to combat gram-positive pathogens. Molecules, 29.","DOI":"10.3390\/molecules29174065"},{"key":"ref_15","unstructured":"Bui, T., Patel, P., and Preuss, C.V. (2024). Cephalosporins. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"ii30","DOI":"10.1093\/jac\/dkab175","article-title":"Consumption of macrolides, lincosamides and streptogramins in the community, European Union\/European Economic Area, 1997\u20132017","volume":"76","author":"Adriaenssens","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_17","unstructured":"Patel, P.H., and Hashmi, M.F. (2023). Macrolides. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"a027029","DOI":"10.1101\/cshperspect.a027029","article-title":"Aminoglycosides: An overview","volume":"6","author":"Krause","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Thy, M., Timsit, J.-F., and de Montmollin, E. (2023). Aminoglycosides for the treatment of severe infection due to resistant gram-negative pathogens. Antibiotics, 12.","DOI":"10.3390\/antibiotics12050860"},{"key":"ref_20","unstructured":"Chao, Y.-S., and Farrah, K. (2019). Fluoroquinolones for the Treatment of Urinary Tract Infection: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Meni\u00f1o, I., Garc\u00eda, V., Lumbreras-Iglesias, P., Fern\u00e1ndez, J., and Mora, A. (2024). Fluoroquinolone resistance in complicated urinary tract infections: Association with the increased occurrence and diversity of Escherichia coli of clonal complex 131, together with ST1193. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1351618"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"105103","DOI":"10.1016\/j.cmicom.2025.105103","article-title":"To heal or harm: A systematic review of the role of fluoroquinolones in periprosthetic joint infections","volume":"2","author":"Tevell","year":"2025","journal-title":"CMI Commun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00210-023-02622-2","article-title":"Re-evaluating the suitability of using fluoroquinolones in the treatment of infections in the context of FQ consumption and correlating changes to microorganism resistance levels in EU\/EEA countries between 2016 and 2021","volume":"397","author":"Serwacki","year":"2024","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2165\/00003495-199447050-00008","article-title":"Teicoplanin: A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy","volume":"47","author":"Brogden","year":"1994","journal-title":"Drugs"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Mahdizade Ari, M., Dashtbin, S., Ghasemi, F., Shahroodian, S., Kiani, P., Bafandeh, E., Darbandi, T., Ghanavati, R., and Darbandi, A. (2023). Nitrofurantoin: Properties and potential in treatment of urinary tract infection: A narrative review. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1148603"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2082693","DOI":"10.1155\/2016\/2082693","article-title":"Fosfomycin: A first-line oral therapy for acute uncomplicated cystitis","volume":"2016","author":"Zhanel","year":"2016","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11306-006-0037-z","article-title":"Statistical strategies for avoiding false discoveries in metabolomics and related experiments","volume":"2","author":"Broadhurst","year":"2006","journal-title":"Metabolomics"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e70255","DOI":"10.1002\/nbm.70255","article-title":"Analyzing Nicotine Action Against Amyloid Toxicity by NMR-Pharmacometabolomics: An Exploratory Study","volume":"39","author":"Napolitano","year":"2026","journal-title":"NMR Biomed."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/6\/612\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:51:58Z","timestamp":1781679118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/6\/612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["antibiotics15060612"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15060612","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]}}}